BioPharma « Terug naar discussie overzicht

HEB Memispherx

61 Posts, Pagina: 1 2 3 4 » | Laatste

Omlaag ↓

[verwijderd] 11 mei 2009 21:01

BRIEF-Hemispherx Biopharma announces public equity offerings

May 11 (Reuters) - Hemispherx Biopharma, Inc : * Announces $18.3 million public equity offerings * Says offering priced at $1.10 per share

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) ((For more news, please click here [HEB.A]))

Sheff quote:

Hemispherx Biopharma (HEB): Ampligen (Poly I: Poly C12U) NDA (three month PDUFA decision date delay was announced on 2/18/09 as additional data was submitted by HEB within three months of original decision date). Ampligen is an experimental treatment for chronic fatigue syndrome (which has no FDA-approved treatments) and the drug has an Orphan Drug Status with a PDUFA decision date of 5/25/09.

[verwijderd] 11 mei 2009 21:08

verder geen goede LT play hoor. veel haken en ogen

[verwijderd] 11 mei 2009 21:13

vooral goed voorbeeld..
lekker opogelopen... extra hoog open... en daarna nieuws van verwatering

[verwijderd] 12 mei 2009 07:08

Voor dit soort aandelen geldt altijd op tijd winst nemen en niet te gretig worden.

[verwijderd] 15 mei 2009 20:18

quote:
crackedtooth schreef:
vooral goed voorbeeld..
lekker opogelopen... extra hoog open... en daarna nieuws van verwatering

Toch vandaag ruim 30% in de plus met een flink volume.

welshterrier 5 18 mei 2009 21:08

quote:
domus muris schreef:
[quote=crackedtooth]
vooral goed voorbeeld..
lekker opogelopen... extra hoog open... en daarna nieuws van verwatering
[/quote]

Toch vandaag ruim 30% in de plus met een flink volume.

nu bijna 2.00!!!!!!!!!!!!!!!!ruim 50 % in de plus

welshterrier 5 18 mei 2009 23:41

nabeurs 2,05 nu, is al 2,11 geweest

[verwijderd] 18 mei 2009 23:53

Pump en dump trade
maar geniet ervan als je trader bent

HEB inquiry

Hemispherx Biopharma Comments On Market Activity

PHILADELPHIA, May 15, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) stated that in view of the unusual market activity in the Company's stock, the NYSE Amex has contacted the Company and requested that the Company issue a public statement indicating as to whether there are any corporate developments which may explain the unusual activity. The Company stated that there have been no material events other than as disclosed in its recent press releases and its filings with the Securities and Exchange Commission that would explain the high volume market activity.

finance.yahoo.com/news/Hemispherx-Bio...

welshterrier 5 19 mei 2009 09:13

Er komt een eventuele goedkeuring aan voor de 25 e, dus het is geen pump en dump.............
vlg mij

[verwijderd] 19 mei 2009 09:16

quote:
welshterrier schreef:
Er komt een eventuele goedkeuring aan voor de 25 e, dus het is geen pump en dump.............
vlg mij

wel geklooi, zo een sec message komt er niet iedere dag

en nogmaals wil niet zeggen dat er geen winst gehaald kan worden erin

welshterrier 5 19 mei 2009 09:19

misschien iets gelekt, kan ook

welshterrier 5 19 mei 2009 13:56

voorbeurs 2,20

welshterrier 5 19 mei 2009 14:30

2,30 al gezien

[verwijderd] 19 mei 2009 15:29

quote:
welshterrier schreef:
2,30 al gezien

en heb je hem geshort dan?

[verwijderd] 19 mei 2009 16:12

HEB offers shares/warrants six days before PDUFA date:

tja....waarom zou je dat doen

welshterrier 5 19 mei 2009 18:18

quote:
crackedtooth schreef:
[quote=welshterrier ]
2,30 al gezien
[/quote]
en heb je hem geshort dan?

ben geen shorter, zou niet weten hoe dat moet
pfffffffffffffffff

welshterrier 5 21 mei 2009 10:27

vandaag weer verder hier koers nabeurs 1,71
misschien vandaag of zeker morgen nieuws hier.

[verwijderd] 23 mei 2009 17:50

Chronic Fatigue Syndrome Treatment: FDA's Ampligen Decision Imminent
Friday May 22, 2009

Will the millions of people with chronic fatigue syndrome (CFS or ME/CFS) finally have an FDA-approved drug treatment? We should know soon, as the long-awaited decision on Ampligen (poly I: poly C12U) is due on or around May 25.

Ampligen has languished in the "experimental" stage for 30 years. Then, in October 2007, Hemispherex Biopharma Inc. put in a New Drug Application for Ampligen as the first ever FDA approved treatment for ME/CFS. In July 2008, the company responded to questions sent back by the FDA, and the application was officially accepted. The decision was originally due in late February, but the FDA at that time announced it needed 3 more months. Now, it's just a matter of time before we hear yea or nay.

Ampligen is an immume-system modulator that works by jump-starting your body's natural anti-viral pathway and regulating levels of Rnase L (a substance in your cells that attacks viruses), which can be high in people with ME/CFS. Studies show it's more effective and has far fewer side effects than other drugs in its class. Ampligen has also been studied as a possible treatment for AIDS, avian flu, and certain types of cancer.

This drug has been available to certain U.S. clinics for several years, and there's a lot of evidence (both clinical and experiential) showing that it works. Some doctors claim they've seen improvement in 80% of people with ME/CFS who take Ampligen, and significant improvement in about 50%. They say a lot of seriously disabled people have even been able to go back to work because of it.

Side effects are reportedly mild and include flu-like symptoms, dizziness and confusion. (After living with ME/CFS, would you even recognize those as side effects?)

Here's more info from the manufacturer: Ampligen.

chronicfatigue.about.com/b/2009/05/22...

[verwijderd] 24 mei 2009 09:43

Misschien morgen positief nieuws?????????

Als je de artikelen leest,kan het bijna niet meer mis,maar dat is al vaker gedacht.

Stukje uit een artikel,je zou toch zeggen dat...................................nah,eerst maar eens zien.

Vriendelijke groet.

As reported in BioMedReports this past week, HEB is expecting to hear from the FDA this coming week as to whether Ampligen receives approval as a chronic fatigue syndrome treatment.

With the "boats loads" of safety data available, Ampligen could quickly be developed for H1N1 flu strain, Piros said. He noted that Hemispherx already has been in discussions with the CDC about its product

biomedreports.com/articles/most-popul...

junkbond 24 mei 2009 11:11

Misschien morgen positief nieuws..

zou kunnen maar handelen kan dinsdag pas ,memorial day morgen

61 Posts, Pagina: 1 2 3 4 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 913,39 +2,76 +0,30% 15 mei


Germany40^	18.875,90	+0,03%
BEL 20	4.029,25	+1,52%
Europe50^	5.105,38	+0,09%
US30^	39.913,30	0,00%
Nasd100^	18.593,20	0,00%
US500^	5.307,40	0,00%
Japan225^	38.699,80	0,00%
Gold spot	2.395,53	+0,38%
EUR/USD	1,0894	+0,70%
WTI	78,39	0,00%